News Release
2020
-
February 3, 2020
Transfer of distribution operation of MARIZEV® type-2 diabetes treatment
-
January 22, 2020
Kissei announces the publication of the results of phase III clinical trials of rovatirelin for the treatment of spinocerebellar degeneration in the Journal of Neurology, Neurosurgery, and Psychiatry
